BE622943A - Therapeutic compositions, containing emetine derivatives. - Google Patents
Therapeutic compositions, containing emetine derivatives.Info
- Publication number
- BE622943A BE622943A BE622943A BE622943A BE622943A BE 622943 A BE622943 A BE 622943A BE 622943 A BE622943 A BE 622943A BE 622943 A BE622943 A BE 622943A BE 622943 A BE622943 A BE 622943A
- Authority
- BE
- Belgium
- Prior art keywords
- therapeutic compositions
- emetine
- derivatives
- emetine derivatives
- therapeutic
- Prior art date
Links
- AUVVAXYIELKVAI-CKBKHPSWSA-N emetine Chemical class N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC AUVVAXYIELKVAI-CKBKHPSWSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
- C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
- C07D455/08—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems having an isoquinolyl-1, a substituted isoquinolyl-1 or an alkylenedioxyisoquinolyl-1 radical linked through only one carbon atom, attached in position 2, e.g. emetine
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/26—Removing halogen atoms or halogen-containing groups from the molecule
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB35268/61A GB982150A (en) | 1961-09-29 | 1961-09-29 | Therapeutic resin complexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE622943A true BE622943A (en) | 1963-01-16 |
Family
ID=10375806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE622943A BE622943A (en) | 1961-09-29 | 1962-09-27 | Therapeutic compositions, containing emetine derivatives. |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE622943A (en) |
| FR (1) | FR2489M (en) |
| GB (1) | GB982150A (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4076804A (en) * | 1975-07-18 | 1978-02-28 | Abbott Laboratories | Erythromycin therapy |
| NZ185772A (en) * | 1976-11-26 | 1978-12-18 | Pennwalt Corp | A pharmaceutical composition comprising a complex of a drug absorbed on an ion exchange resin the complex being treated with a solvating agent and then coated |
| NZ219925A (en) * | 1986-07-30 | 1989-06-28 | Pennwalt Corp | Polymer-treated sulphonic acid cationic exchange resin particles |
| US4859461A (en) * | 1986-07-30 | 1989-08-22 | Fisons Corporation | Coatable ion exchange resins |
| IE62100B1 (en) * | 1986-07-30 | 1994-12-14 | Fisons Corp | Coated ion exchange resins |
| US4859462A (en) * | 1986-07-30 | 1989-08-22 | Fisons Corporation | Polymer-treated ion exchange resins |
| CA2002492A1 (en) * | 1988-11-11 | 1990-05-11 | Sandra T. A. Malkowska | Pharmaceutical ion exchange resin composition |
| US20070036843A1 (en) * | 2005-01-28 | 2007-02-15 | Collegium Pharmaceutical, Inc. | Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents |
-
1961
- 1961-09-29 GB GB35268/61A patent/GB982150A/en not_active Expired
-
1962
- 1962-09-27 BE BE622943A patent/BE622943A/en unknown
- 1962-09-28 FR FR910733A patent/FR2489M/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| GB982150A (en) | 1965-02-03 |
| FR2489M (en) | 1964-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE622943A (en) | Therapeutic compositions, containing emetine derivatives. | |
| FR2144M (en) | Pharmaceutical compositions containing radioactive sources. | |
| DK103662C (en) | Men's underwear. | |
| FR1902M (en) | New drugs derived from isothiazole. | |
| FR2517M (en) | Pharmaceutical compositions containing propanolamines. | |
| FR6247M (en) | New therapeutic applications of 2,3-epithioids. | |
| FR2075M (en) | New derivatives of 6-methyl- and 1,6-dimethyl-ergoline i. | |
| BE601304A (en) | Stable compositions containing isoproteronol. | |
| FR2247M (en) | New drug compositions against canker sore. | |
| FR2477M (en) | Amino derivatives of n-cyclopropylbenzylamines. | |
| BE626351A (en) | Compositions containing 2,6-dichlorobenzamidine as an active ingredient | |
| FR3173M (en) | Therapeutic derivatives of aralkoyl-2-mercapto-benzazoles. | |
| FR2849M (en) | Composition for dental care. | |
| FR3461M (en) | New drug compositions containing acetyl-glutamine derivatives. | |
| FR2260M (en) | 16 alpha-chloroprednisolone derivatives and therapeutic compositions containing them. | |
| BE619267A (en) | Depolymerized algin derivatives. | |
| FR2985M (en) | Pharmaceutical compositions containing indole derivatives. | |
| FR2395M (en) | Therapeutic compositions containing 3,5-dimethylisoxazole. | |
| FR2156M (en) | New therapeutic compositions. | |
| FR1722M (en) | New drugs consisting of 4- (pyridoylamido-acylamino) -1-phenyl-2,3-dimethyl-pyrazolones- (5). | |
| FR1373M (en) | Therapeutic composition. | |
| OA00656A (en) | Compositions containing alkylated derivatives of phlorophenone. | |
| FR2398M (en) | Compositions causing anorexia. | |
| BE585967A (en) | Pharmaceutical compositions containing benzylhydrazine derivatives. | |
| FR1777M (en) | Medicinal product containing preparations for hypertension. |